Head, Pharmacometrics
Jazz Pharmaceuticals Inc
Dr. Honghui Zhou received his PhD in Pharmaceutics from the University of Iowa. He is currently Head of Pharmacometrics at Jazz Pharmaceuticals. Honghui spent most of his prior career at Janssen R&D and Centocor (Johnson & Johnson) with different roles: Head of Pharmacometrics, Head of Clinical Pharmacology (Immunology), and Head of Biotherapeutics PK/PD and Modeling & Simulation. Before he joined Johnson & Johnson, he was Director of Clinical Pharmacology at Wyeth Research (now part of Pfizer). He was elected Janssen Fellow, and was the recipient of numerous Johnson & Johnson awards including the Spark Innovation Award, the Philip B. Hofmann Award, and Janssen Innovation Leadership Award.
Honghui is board-certified by American Board of Clinical Pharmacology. He is a Fellow of the American College of Clinical Pharmacology (ACCP), and the American Association of Pharmaceutical Scientists (AAPS). He was a past ACCP Regent (2009-2013, 2016-2020) and is an Honorary Regent. He also served as past Co-Chairs of ACCP Annual Meetings (2013, 2016, 2020), and was a recipient of ACCP NTK Memorial Distinguished Service Award in 2022. He currently serves as Associate Editor for Journal of Clinical Pharmacology and Assistant Editor for mAbs. He has published more than 150 peer-reviewed manuscripts and book chapters, and co-edited three books (Wiley) in therapeutic protein ADME and translational PK/PD, drug-drug interactions, and individualized therapy strategy.
Disclosure information not submitted.
Tuesday, September 10, 2024
1:30 PM – 3:00 PM ET
Tuesday, September 10, 2024
1:30 PM – 3:00 PM ET
Tuesday, September 10, 2024
3:30 PM – 5:00 PM ET